Rhinostics Inc

Rhinostics Inc specializes in in-vitro diagnostic (IVD) devices primarily focused on home specimen collection. Their product line includes general specimen collection kits for at-home use, oral and upper respiratory tract swabs for collecting clinical samples, non-insulated specimen container mailers for transporting samples, single-use assay containers, and capillary blood collection tubes without additives. These devices are designed to facilitate safe and convenient sample collection outside of clinical settings.

Rhinostics Inc is based in the United States. Since their devices are in-vitro diagnostics, they operate under the regulatory framework established by the U.S. Food and Drug Administration (FDA). The company ensures compliance with FDA requirements for IVDs, including registration and listing of their devices in relevant databases.

Rhinostics Inc’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system is used to track and identify medical devices throughout their distribution and helps ensure transparency and traceability in the regulatory process.

All of Rhinostics Inc’s devices fall under Class I regulatory classification in the United States. Class I devices are generally considered to pose the lowest risk and typically do not require pre-market approval, though they still must comply with FDA registration, listing, and other applicable requirements to ensure safety and performance.